Targeting Cdc20 as a novel cancer therapeutic strategy

Pharmacology and Therapeutics

Volumn 151, Issue , 2015, Pages 141-151

  Wang, Lixia ^a   Zhang, Jinfang ^b   Wan, Lixin ^b   Zhou, Xiuxia ^a   Wang, Zhiwei ^a   Wei, Wenyi ^b  

^a SOOCHOW UNIVERSITY   (China)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cancer; Cdc20; Drug; E3 ligase; SCF; Target

Indexed keywords

6 BROMINATED COUMARIN HYDRAZIDE HYDRAZONE DERIVATIVE; ANAPHASE PROMOTING COMPLEX; ANTINEOPLASTIC AGENT; APCIN; AURORA A KINASE; AURORA B KINASE; BORTEZOMIB; CARFILZOMIB; CARP 1 FUNCTIONAL MIMETIC 4; CELL CYCLE PROTEIN 20; CELL CYCLE PROTEIN 20 INHIBITOR; CELL CYCLE PROTEIN 6; CYCLIN A2; DELANZOMIB; GANODERMANONTRIOL; GEMININ; GENISTEIN; OPROZOMIB; POLO LIKE KINASE 1; PRO TOSYLARGININE METHYL ESTER; PROTEIN; PROTEIN INHIBITOR; S PHASE KINASE ASSOCIATED PROTEIN 2; SALINOSPORAMIDE A; SULFONAMIDE; TOSYLARGININE METHYL ESTER; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; UNINDEXED DRUG; UVOMORULIN; WITHAFERIN A; CDC20 PROTEIN, HUMAN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BRAIN DEVELOPMENT; BREAST CANCER; CANCER THERAPY; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CHROMOSOMAL INSTABILITY; COLORECTAL CANCER; DRUG TARGETING; GLIOBLASTOMA; HUMAN; LIVER CELL CARCINOMA; LUNG CANCER; METASTASIS; MITOSIS INHIBITION; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DEGRADATION; STOMACH CANCER; TUMOR GROWTH; UBIQUITINATION; ANTAGONISTS AND INHIBITORS; BRAIN; CELL CYCLE; CELL DIFFERENTIATION; CYTOLOGY; EUKARYOTIC FLAGELLUM; METABOLISM; NEOPLASMS; NERVE CELL; NERVE CELL PLASTICITY; PATHOLOGY; PHYSIOLOGY;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BRAIN; CDC20 PROTEINS; CELL CYCLE; CELL DIFFERENTIATION; CILIA; HUMANS; NEOPLASMS; NEURONAL PLASTICITY; NEURONS; UBIQUITINATION;

EID: 84930088030     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2015.04.002     Document Type: Review

References (155)

1. J. Adams The proteasome: a suitable antineoplastic target Nat Rev Cancer 4 2004 349 360
2. T. Akiyama, P. Bouillet, T. Miyazaki, Y. Kadono, H. Chikuda, and U.I. Chung Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim EMBO J 22 2003 6653 6664
3. T. Akiyama, C.R. Dass, and P.F. Choong Bim-targeted cancer therapy: a link between drug action and underlying molecular changes Mol Cancer Ther 8 2009 3173 3180
4. T. Akiyama, and S. Tanaka Bim: guardian of tissue homeostasis and critical regulator of the immune system, tumorigenesis and bone biology Arch Immunol Ther Exp (Warsz) 59 2011 277 287
5. A. Allegra, A. Alonci, D. Gerace, S. Russo, V. Innao, and L. Calabro New orally active proteasome inhibitors in multiple myeloma Leuk Res 38 2014 1 9
6. V. Amador, S. Ge, P.G. Santamaria, D. Guardavaccaro, and M. Pagano APC/C(Cdc20) controls the ubiquitin-mediated degradation of p21 in prometaphase Mol Cell 27 2007 462 473
7. C. Andreu-Vieyra, and J.R. Berenson Carfilzomib in multiple myeloma Expert Opin Biol Ther 14 2014 1685 1699
8. M. Araki, R.P. Wharton, Z. Tang, H. Yu, and M. Asano Degradation of origin recognition complex large subunit by the anaphase-promoting complex in Drosophila EMBO J 22 2003 6115 6126
9. S. Banerjee, Y. Li, Z. Wang, and F.H. Sarkar Multi-targeted therapy of cancer by genistein Cancer Lett 269 2008 226 242
10. T. Banerjee, S. Nath, and S. Roychoudhury DNA damage induced p53 downregulates Cdc20 by direct binding to its promoter causing chromatin remodeling Nucleic Acids Res 37 2009 2688 2698
11. T. Bashir, N.V. Dorrello, V. Amador, D. Guardavaccaro, and M. Pagano Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase Nature 428 2004 190 193
12. F. Bassermann, R. Eichner, and M. Pagano The ubiquitin proteasome system - implications for cell cycle control and the targeted treatment of cancer Biochim Biophys Acta 1843 2014 150 162
13. J. Bieniek, C. Childress, M.D. Swatski, and W. Yang COX-2 inhibitors arrest prostate cancer cell cycle progression by down-regulation of kinetochore/centromere proteins Prostate 74 2014 999 1011
14. V.N. Budhavarapu, E.D. White, C.S. Mahanic, L. Chen, F.T. Lin, and W.C. Lin Regulation of E2F1 by APC/C Cdh1 via K11 linkage-specific ubiquitin chain formation Cell Cycle 11 2012 2030 2038
15. T. Caravita, P. de Fabritiis, A. Palumbo, S. Amadori, and M. Boccadoro Bortezomib: efficacy comparisons in solid tumors and hematologic malignancies Nat Clin Pract Oncol 3 2006 374 387
16. A. Castro, S. Vigneron, C. Bernis, J.C. Labbe, and T. Lorca Xkid is degraded in a D-box, KEN-box, and A-box-independent pathway Mol Cell Biol 23 2003 4126 4138
17. L. Chang, and D. Barford Insights into the anaphase-promoting complex: a molecular machine that regulates mitosis Curr Opin Struct Biol 29 2014 1 9
18. D.Z. Chang, Y. Ma, B. Ji, Y. Liu, P. Hwu, and J.L. Abbruzzese Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression J Hematol Oncol 5 2012 15
19. L. Chang, Z. Zhang, J. Yang, S.H. McLaughlin, and D. Barford Molecular architecture and mechanism of the anaphase-promoting complex Nature 513 2014 388 393
20. Z. Chen, Y. Yu, D. Fu, Z. Li, X. Niu, and M. Liao Functional roles of PC-PLC and Cdc20 in the cell cycle, proliferation, and apoptosis Cell Biochem Funct 28 2010 249 257
21. H.J. Cho, E.H. Lee, S.H. Han, H.J. Chung, J.H. Jeong, and J. Kwon Degradation of human RAP80 is cell cycle regulated by Cdc20 and Cdh1 ubiquitin ligases Mol Cancer Res 10 2012 615 625
22. J.W. Choi, Y. Kim, J.H. Lee, and Y.S. Kim High expression of spindle assembly checkpoint proteins CDC20 and MAD2 is associated with poor prognosis in urothelial bladder cancer Virchows Arch 463 2013 681 687
23. A.C. Chun, K.H. Kok, and D.Y. Jin REV7 is required for anaphase-promoting complex-dependent ubiquitination and degradation of translesion DNA polymerase REV1 Cell Cycle 12 2013 365 378
24. L. Clijsters, J. Ogink, and R. Wolthuis The spindle checkpoint, APC/C(Cdc20), and APC/C(Cdh1) play distinct roles in connecting mitosis to S phase J Cell Biol 201 2013 1013 1026
25. P. Clute, and J. Pines Temporal and spatial control of cyclin B1 destruction in metaphase Nat Cell Biol 1 1999 82 87
26. S. Cory, and J.M. Adams The Bcl2 family: regulators of the cellular life-or-death switch Nat Rev Cancer 2 2002 647 656
27. M.S. Cragg, C. Harris, A. Strasser, and C.L. Scott Unleashing the power of inhibitors of oncogenic kinases through BH3 mimetics Nat Rev Cancer 9 2009 321 326
28. Y. Cui, X. Cheng, C. Zhang, Y. Zhang, S. Li, and C. Wang Degradation of the human mitotic checkpoint kinase Mps1 is cell cycle-regulated by APC-cCdc20 and APC-cCdh1 ubiquitin ligases J Biol Chem 285 2010 32988 32998
29. B. Dai, A. Gong, Z. Jing, K.D. Aldape, S.H. Kang, and R. Sawaya Forkhead box M1 is regulated by heat shock factor 1 and promotes glioma cells survival under heat shock stress J Biol Chem 288 2013 1634 1642
30. T. Das, K.S. Roy, T. Chakrabarti, S. Mukhopadhyay, and S. Roychoudhury Withaferin A modulates the Spindle assembly checkpoint by degradation of Mad2-Cdc20 complex in colorectal cancer cell lines Biochem Pharmacol 91 2014 31 39
31. E. Dehan, F. Bassermann, D. Guardavaccaro, G. Vasiliver-Shamis, M. Cohen, and K.N. Lowes betaTrCP- and Rsk1/2-mediated degradation of BimEL inhibits apoptosis Mol Cell 33 2009 109 116
32. N. den Elzen, and J. Pines Cyclin A is destroyed in prometaphase and can delay chromosome alignment and anaphase J Cell Biol 153 2001 121 136
33. B. Di Fiore, N.E. Davey, A. Hagting, D. Izawa, J. Mansfeld, and T.J. Gibson The ABBA motif binds APC/C activators and is shared by APC/C substrates and regulators Dev Cell 32 2015 358 372
34. Z.Y. Ding, H.R. Wu, J.M. Zhang, G.R. Huang, and D.D. Ji Expression characteristics of CDC20 in gastric cancer and its correlation with poor prognosis Int J Clin Exp Pathol 7 2014 722 727
35. Q.P. Dou, and J.A. Zonder Overview of proteasome inhibitor-based anti-cancer therapies: perspective on bortezomib and second generation proteasome inhibitors versus future generation inhibitors of ubiquitin-proteasome system Curr Cancer Drug Targets 14 2014 517 536
36. G. Fang, H. Yu, and M.W. Kirschner The checkpoint protein MAD2 and the mitotic regulator CDC20 form a ternary complex with the anaphase-promoting complex to control anaphase initiation Genes Dev 12 1998 1871 1883
37. I. Foe, and D. Toczyski Structural biology: a new look for the APC Nature 470 2011 182 183
38. R. Fraschini, E. Formenti, G. Lucchini, and S. Piatti Budding yeast Bub2 is localized at spindle pole bodies and activates the mitotic checkpoint via a different pathway from Mad2 J Cell Biol 145 1999 979 991
39. D. Gao, H. Inuzuka, M. Korenjak, A. Tseng, T. Wu, and L. Wan Cdh1 regulates cell cycle through modulating the claspin/Chk1 and the Rb/E2F1 pathways Mol Biol Cell 20 2009 3305 3316
40. S. Geley, E. Kramer, C. Gieffers, J. Gannon, J.M. Peters, and T. Hunt Anaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint J Cell Biol 153 2001 137 148
41. M.D. Gurden, A.J. Holland, W. van Zon, A. Tighe, M.A. Vergnolle, and D.A. Andres Cdc20 is required for the post-anaphase, KEN-dependent degradation of centromere protein F J Cell Sci 123 2010 321 330
42. M.V. Hadjihannas, D.B. Bernkopf, M. Bruckner, and J. Behrens Cell cycle control of Wnt/beta-catenin signalling by conductin/axin2 through CDC20 EMBO Rep 13 2012 347 354
43. R.S. Hames, S.L. Wattam, H. Yamano, R. Bacchieri, and A.M. Fry APC/C-mediated destruction of the centrosomal kinase Nek2A occurs in early mitosis and depends upon a cyclin A-type D-box EMBO J 20 2001 7117 7127
44. M.E. Harley, L.A. Allan, H.S. Sanderson, and P.R. Clarke Phosphorylation of Mcl-1 by CDK1-cyclin B1 initiates its Cdc20-dependent destruction during mitotic arrest EMBO J 29 2010 2407 2420
45. L.H. Hartwell, J. Culotti, and B. Reid Genetic control of the cell-division cycle in yeast. I. Detection of mutants Proc Natl Acad Sci U S A 66 1970 352 359
46. L.H. Hartwell, R.K. Mortimer, J. Culotti, and M. Culotti Genetic control of the cell division cycle in yeast: v. genetic analysis of CDC mutants Genetics 74 1973 267 286
47. M.J. Hayes, Y. Kimata, S.L. Wattam, C. Lindon, G. Mao, and H. Yamano Early mitotic degradation of Nek2A depends on Cdc20-independent interaction with the APC/C Nat Cell Biol 8 2006 607 614
48. D. Hoeller, C.M. Hecker, and I. Dikic Ubiquitin and ubiquitin-like proteins in cancer pathogenesis Nat Rev Cancer 6 2006 776 788
49. D. Hu, X. Qiao, G. Wu, and Y. Wan The emerging role of APC/CCdh1 in development Semin Cell Dev Biol 22 2011 579 585
50. H.C. Huang, J. Shi, J.D. Orth, and T.J. Mitchison Evidence that mitotic exit is a better cancer therapeutic target than spindle assembly Cancer Cell 16 2009 347 358
51. G. Ichim, M. Mola, M.G. Finkbeiner, M.P. Cros, Z. Herceg, and H. Hernandez-Vargas The histone acetyltransferase component TRRAP is targeted for destruction during the cell cycle Oncogene 33 2014 181 192
52. D. Izawa, and J. Pines The mitotic checkpoint complex binds a second CDC20 to inhibit active APC/C Nature 517 2015 631 634
53. S.S. Jackson, C. Oberley, C.P. Hooper, K. Grindle, S. Wuerzberger-Davis, and J. Wolff Withaferin A disrupts ubiquitin-based NEMO reorganization induced by canonical NF-kappaB signaling Exp Cell Res 331 2015 58 72
54. S. Jamal, V.T. Cheriyan, M. Muthu, S. Munie, E. Levi, and A.E. Ashour CARP-1 functional mimetics are a novel class of small molecule inhibitors of malignant pleural mesothelioma cells PLoS One 9 2014 e89146
55. A. Janssen, and R.H. Medema Mitosis as an anti-cancer target Oncogene 30 2011 2799 2809
56. P. Ji, S.M. Smith, Y. Wang, R. Jiang, S.W. Song, and B. Li Inhibition of gliomagenesis and attenuation of mitotic transition by MIIP Oncogene 29 2010 3501 3508
57. J. Jiang, A. Jedinak, and D. Sliva Ganodermanontriol (GDNT) exerts its effect on growth and invasiveness of breast cancer cells through the down-regulation of CDC20 and uPA Biochem Biophys Res Commun 415 2011 325 329
58. J. Jiang, and D. Sliva Novel medicinal mushroom blend suppresses growth and invasiveness of human breast cancer cells Int J Oncol 37 2010 1529 1536
59. J. Jiang, A. Thyagarajan-Sahu, V. Krchnak, A. Jedinak, G.E. Sandusky, and D. Sliva NAHA, a novel hydroxamic acid-derivative, inhibits growth and angiogenesis of breast cancer in vitro and in vivo PLoS One 7 2012 e34283
60. L. Jin, A. Williamson, S. Banerjee, I. Philipp, and M. Rape Mechanism of ubiquitin-chain formation by the human anaphase-promoting complex Cell 133 2008 653 665
61. S.S. Kakar, M.Z. Ratajczak, K.S. Powell, M. Moghadamfalahi, D.M. Miller, and S.K. Batra Withaferin a alone and in combination with Cisplatin suppresses growth and metastasis of ovarian cancer by targeting putative cancer stem cells PLoS One 9 2014 e107596
62. H. Karra, H. Repo, I. Ahonen, E. Loyttyniemi, R. Pitkanen, and M. Lintunen Cdc20 and securin overexpression predict short-term breast cancer survival Br J Cancer 110 2014 2905 2913
63. T. Kato, Y. Daigo, M. Aragaki, K. Ishikawa, M. Sato, and M. Kaji Overexpression of CDC20 predicts poor prognosis in primary non-small cell lung cancer patients J Surg Oncol 106 2012 423 430
64. T. Kidokoro, C. Tanikawa, Y. Furukawa, T. Katagiri, Y. Nakamura, and K. Matsuda CDC20, a potential cancer therapeutic target, is negatively regulated by p53 Oncogene 27 2008 1562 1571
65. Y. Kim, J.W. Choi, J.H. Lee, and Y.S. Kim MAD2 and CDC20 are upregulated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the uterine cervix Int J Gynecol Pathol 33 2014 517 523
66. H.S. Kim, Y.K. Jeon, G.H. Ha, H.Y. Park, Y.J. Kim, and H.J. Shin Functional interaction between BubR1 and securin in an anaphase-promoting complex/cyclosomeCdc20-independent manner Cancer Res 69 2009 27 36
67. A.H. Kim, S.V. Puram, P.M. Bilimoria, Y. Ikeuchi, S. Keough, and M. Wong A centrosomal Cdc20-APC pathway controls dendrite morphogenesis in postmitotic neurons Cell 136 2009 322 336
68. J.M. Kim, H.Y. Sohn, S.Y. Yoon, J.H. Oh, J.O. Yang, and J.H. Kim Identification of gastric cancer-related genes using a cDNA microarray containing novel expressed sequence tags expressed in gastric cancer cells Clin Cancer Res 11 2005 473 482
69. H.S. Kim, A. Vassilopoulos, R.H. Wang, T. Lahusen, Z. Xiao, and X. Xu SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity Cancer Cell 20 2011 487 499
70. S. Kim, and H. Yu Mutual regulation between the spindle checkpoint and APC/C Semin Cell Dev Biol 22 2011 551 558
71. E.J. Kuipers, T. Rosch, and M. Bretthauer Colorectal cancer screening - optimizing current strategies and new directions Nat Rev Clin Oncol 10 2013 130 142
72. K. Kulkarni, Z. Zhang, L. Chang, J. Yang, P.C. da Fonseca, and D. Barford Building a pseudo-atomic model of the anaphase-promoting complex Acta Crystallogr D Biol Crystallogr 69 2013 2236 2243
73. P.S. Kwan, C.C. Lau, Y.T. Chiu, C. Man, J. Liu, and K.D. Tang Daxx regulates mitotic progression and prostate cancer predisposition Carcinogenesis 34 2013 750 759
74. A.W. Lau, H. Fukushima, and W. Wei The Fbw7 and betaTRCP E3 ubiquitin ligases and their roles in tumorigenesis Front Biosci 17 2012 2197 2212
75. J. Li, J.Z. Gao, J.L. Du, Z.X. Huang, and L.X. Wei Increased CDC20 expression is associated with development and progression of hepatocellular carcinoma Int J Oncol 45 2014 1547 1555
76. M. Li, J.P. York, and P. Zhang Loss of Cdc20 causes a securin-dependent metaphase arrest in two-cell mouse embryos Mol Cell Biol 27 2007 3481 3488
77. D. Li, J. Zhu, P.F. Firozi, J.L. Abbruzzese, D.B. Evans, and K. Cleary Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer Clin Cancer Res 9 2003 991 997
78. X. Li, F. Zhu, J. Jiang, C. Sun, X. Wang, and M. Shen Synergistic antitumor activity of withaferin A combined with oxaliplatin triggers reactive oxygen species-mediated inactivation of the PI3K/AKT pathway in human pancreatic cancer cells Cancer Lett 357 2015 219 230
79. H.J. Lim, N.V. Dimova, M.K. Tan, F.D. Sigoillot, R.W. King, and Y. Shi The G2/M regulator histone demethylase PHF8 is targeted for degradation by the anaphase-promoting complex containing CDC20 Mol Cell Biol 33 2013 4166 4180
80. H.H. Lim, P.Y. Goh, and U. Surana Cdc20 is essential for the cyclosome-mediated proteolysis of both Pds1 and Clb2 during M phase in budding yeast Curr Biol 8 1998 231 234
81. C. Lindon, and J. Pines Ordered proteolysis in anaphase inactivates Plk1 to contribute to proper mitotic exit in human cells J Cell Biol 164 2004 233 241
82. S. Lipkowitz, and A.M. Weissman RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis Nat Rev Cancer 11 2011 629 643
83. L.E. Littlepage, and J.V. Ruderman Identification of a new APC/C recognition domain, the A box, which is required for the Cdh1-dependent destruction of the kinase Aurora-A during mitotic exit Genes Dev 16 2002 2274 2285
84. M. Lize, C. Herr, A. Klimke, R. Bals, and M. Dobbelstein MicroRNA-449a levels increase by several orders of magnitude during mucociliary differentiation of airway epithelia Cell Cycle 9 2010 4579 4583
85. A. Mahindra, J. Laubach, N. Raje, N. Munshi, P.G. Richardson, and K. Anderson Latest advances and current challenges in the treatment of multiple myeloma Nat Rev Clin Oncol 9 2012 135 143
86. P. Majumder, S. Bhunia, J. Bhattacharyya, and A. Chaudhuri Inhibiting tumor growth by targeting liposomally encapsulated CDC20siRNA to tumor vasculature: therapeutic RNA interference J Control Release 180 2014 100 108
87. E. Manchado, M. Guillamot, G. de Carcer, M. Eguren, M. Trickey, and I. Garcia-Higuera Targeting mitotic exit leads to tumor regression in vivo: modulation by Cdk1, Mastl, and the PP2A/B55alpha, delta phosphatase Cancer Cell 18 2010 641 654
88. G. Marucci, L. Morandi, E. Magrini, A. Farnedi, E. Franceschi, and R. Miglio Gene expression profiling in glioblastoma and immunohistochemical evaluation of IGFBP-2 and CDC20 Virchows Arch 453 2008 599 609
89. T.J. McGarry, and M.W. Kirschner Geminin, an inhibitor of DNA replication, is degraded during mitosis Cell 93 1998 1043 1053
90. J.R. McLean, D. Chaix, M.D. Ohi, and K.L. Gould State of the APC/C: organization, function, and structure Crit Rev Biochem Mol Biol 46 2011 118 136
91. C. Michaelis, R. Ciosk, and K. Nasmyth Cohesins: chromosomal proteins that prevent premature separation of sister chromatids Cell 91 1997 35 45
92. G. Mondal, S. Sengupta, C.K. Panda, S.M. Gollin, W.S. Saunders, and S. Roychoudhury Overexpression of Cdc20 leads to impairment of the spindle assembly checkpoint and aneuploidization in oral cancer Carcinogenesis 28 2007 81 92
93. I.M. Moura, M.L. Delgado, P.M. Silva, C.A. Lopes, J.B. do Amaral, and L.S. Monteiro High CDC20 expression is associated with poor prognosis in oral squamous cell carcinoma J Oral Pathol Med 43 2014 225 231
94. M. Moustafa-Kamal, I. Gamache, Y. Lu, S. Li, and J.G. Teodoro BimEL is phosphorylated at mitosis by Aurora A and targeted for degradation by betaTrCP1 Cell Death Differ 20 2013 1393 1403
95. A. Nagalingam, P. Kuppusamy, S.V. Singh, D. Sharma, and N.K. Saxena Mechanistic elucidation of the antitumor properties of withaferin a in breast cancer Cancer Res 74 2014 2617 2629
96. K.I. Nakayama, and K. Nakayama Ubiquitin ligases: cell-cycle control and cancer Nat Rev Cancer 6 2006 369 381
97. K. Nasmyth Disseminating the genome: joining, resolving, and separating sister chromatids during mitosis and meiosis Annu Rev Genet 35 2001 673 745
98. T. Nasr, S. Bondock, and M. Youns Anticancer activity of new coumarin substituted hydrazide-hydrazone derivatives Eur J Med Chem 76 2014 539 548
99. A. Ohtoshi, T. Maeda, H. Higashi, S. Ashizawa, and M. Hatakeyama Human p55(CDC)/Cdc20 associates with cyclin A and is phosphorylated by the cyclin A-Cdk2 complex Biochem Biophys Res Commun 268 2000 530 534
100. C. Penas, V. Ramachandran, and N.G. Ayad The APC/C ubiquitin ligase: from cell biology to tumorigenesis Front Oncol 1 2011 60
101. B.O. Petersen, C. Wagener, F. Marinoni, E.R. Kramer, M. Melixetian, and E. Lazzerini Denchi Cell cycle- and cell growth-regulated proteolysis of mammalian CDC6 is dependent on APC-CDH1 Genes Dev 14 2000 2330 2343
102. V.T. Puliyappadamba, W. Wu, D. Bevis, L. Zhang, L. Polin, and R. Kilkuskie Antagonists of anaphase-promoting complex (APC)-2-cell cycle and apoptosis regulatory protein (CARP)-1 interaction are novel regulators of cell growth and apoptosis J Biol Chem 286 2011 38000 38017
103. X. Qiao, L. Zhang, A.M. Gamper, T. Fujita, and Y. Wan APC/C-Cdh1: from cell cycle to cellular differentiation and genomic integrity Cell Cycle 9 2010 3904 3912
104. T. Rajkumar, K. Sabitha, N. Vijayalakshmi, S. Shirley, M.V. Bose, and G. Gopal Identification and validation of genes involved in cervical tumourigenesis BMC Cancer 11 2011 80
105. C.R. Regenbrecht, M. Jung, H. Lehrach, and J. Adjaye The molecular basis of genistein-induced mitotic arrest and exit of self-renewal in embryonal carcinoma and primary cancer cell lines BMC Med Genomics 1 2008 49
106. J.D. Reimann, E. Freed, J.Y. Hsu, E.R. Kramer, J.M. Peters, and P.K. Jackson Emi1 is a mitotic regulator that interacts with Cdc20 and inhibits the anaphase promoting complex Cell 105 2001 645 655
107. J.D. Reimann, B.E. Gardner, F. Margottin-Goguet, and P.K. Jackson Emi1 regulates the anaphase-promoting complex by a different mechanism than Mad2 proteins Genes Dev 15 2001 3278 3285
108. A. Reis, M. Levasseur, H.Y. Chang, D.J. Elliott, and K.T. Jones The CRY box: a second APCcdh1-dependent degron in mammalian cdc20 EMBO Rep 7 2006 1040 1045
109. K.L. Sackton, N. Dimova, X. Zeng, W. Tian, M. Zhang, and T.B. Sackton Synergistic blockade of mitotic exit by two chemical inhibitors of the APC/C Nature 514 2014 646 649
110. F.H. Sarkar, S. Adsule, S. Padhye, S. Kulkarni, and Y. Li The role of genistein and synthetic derivatives of isoflavone in cancer prevention and therapy Mini Rev Med Chem 6 2006 401 407
111. F.H. Sarkar, Y. Li, Z. Wang, and S. Padhye Lesson learned from nature for the development of novel anti-cancer agents: implication of isoflavone, curcumin, and their synthetic analogs Curr Pharm Des 16 2010 1801 1812
112. A. Schreiber, F. Stengel, Z. Zhang, R.I. Enchev, E.H. Kong, and E.P. Morris Structural basis for the subunit assembly of the anaphase-promoting complex Nature 470 2011 227 232
113. G.G. Sedgwick, D.G. Hayward, B. Di Fiore, M. Pardo, L. Yu, and J. Pines Mechanisms controlling the temporal degradation of Nek2A and Kif18A by the APC/C-Cdc20 complex EMBO J 32 2013 303 314
114. O. Shalom, N. Shalva, Y. Altschuler, and B. Motro The mammalian Nek1 kinase is involved in primary cilium formation FEBS Lett 582 2008 1465 1470
115. M. Shike, A.S. Doane, L. Russo, R. Cabal, J. Reis-Filo, and W. Gerald The effects of soy supplementation on gene expression in breast cancer: a randomized placebo-controlled study J Natl Cancer Inst 106 2014
116. M. Shirayama, A. Toth, M. Galova, and K. Nasmyth APC(Cdc20) promotes exit from mitosis by destroying the anaphase inhibitor Pds1 and cyclin Clb5 Nature 402 1999 203 207
117. R.L. Siegel, K.D. Miller, and A. Jemal Cancer statistics, 2015 CA Cancer J Clin 65 2015 5 29
118. J.R. Skaar, J.K. Pagan, and M. Pagano SCF ubiquitin ligase-targeted therapies Nat Rev Drug Discov 13 2014 889 903
119. L. Song, and M. Rape Regulated degradation of spindle assembly factors by the anaphase-promoting complex Mol Cell 38 2010 369 382
120. M.S. Song, S.J. Song, N.G. Ayad, J.S. Chang, J.H. Lee, and H.K. Hong The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex Nat Cell Biol 6 2004 129 137
121. K.J. Stanger, D. Sliva, J. Jiang, and V. Krchnak Synthesis and screening of N-alkyl hydroxamates for inhibition of cancer cell proliferation Comb Chem High Throughput Screen 9 2006 651 661
122. F. Stegmeier, M. Rape, V.M. Draviam, G. Nalepa, M.E. Sowa, and X.L. Ang Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activities Nature 446 2007 876 881
123. M. Storcelova, M. Vician, R. Reis, M. Zeman, and I. Herichova Expression of cell cycle regulatory factors hus1, gadd45a, rb1, cdkn2a and mre11a correlates with expression of clock gene per2 in human colorectal carcinoma tissue Mol Biol Rep 40 2013 6351 6361
124. K. Taniguchi, N. Momiyama, M. Ueda, R. Matsuyama, R. Mori, and Y. Fujii Targeting of CDC20 via small interfering RNA causes enhancement of the cytotoxicity of chemoradiation Anticancer Res 28 2008 1559 1563
125. C.B. Thien, S.A. Dagger, J.H. Steer, F. Koentgen, E.S. Jansen, and C.L. Scott c-Cbl promotes T cell receptor-induced thymocyte apoptosis by activating the phosphatidylinositol 3-kinase/Akt pathway J Biol Chem 285 2010 10969 10981
126. E. Thirthagiri, C.M. Robinson, S. Huntley, M. Davies, L.F. Yap, and S.S. Prime Spindle assembly checkpoint and centrosome abnormalities in oral cancer Cancer Lett 258 2007 276 285
127. R. Verma, N.R. Peters, M. D'Onofrio, G.P. Tochtrop, K.M. Sakamoto, and R. Varadan Ubistatins inhibit proteasome-dependent degradation by binding the ubiquitin chain Science 306 2004 117 120
128. H.C. Vodermaier, C. Gieffers, S. Maurer-Stroh, F. Eisenhaber, and J.M. Peters TPR subunits of the anaphase-promoting complex mediate binding to the activator protein CDH1 Curr Biol 13 2003 1459 1468
129. L. Wan, M. Tan, J. Yang, H. Inuzuka, X. Dai, and T. Wu APC(Cdc20) suppresses apoptosis through targeting Bim for ubiquitination and destruction Dev Cell 29 2014 377 391
130. L. Wan, W. Zou, D. Gao, H. Inuzuka, H. Fukushima, and A.H. Berg Cdh1 regulates osteoblast function through an APC/C-independent modulation of Smurf1 Mol Cell 44 2011 721 733
131. Z. Wang, D. Gao, H. Fukushima, H. Inuzuka, P. Liu, and L. Wan Skp2: a novel potential therapeutic target for prostate cancer Biochim Biophys Acta 1825 2012 11 17
132. R. Wang, K.M. Li, C.H. Zhou, J.L. Xue, C.N. Ji, and J.Z. Chen Cdc20 mediates D-box-dependent degradation of Sp100 Biochem Biophys Res Commun 415 2011 702 706
133. Z. Wang, P. Liu, H. Inuzuka, and W. Wei Roles of F-box proteins in cancer Nat Rev Cancer 14 2014 233 247
134. Q. Wang, J. Tiffen, C.G. Bailey, M.L. Lehman, W. Ritchie, and L. Fazli Targeting amino acid transport in metastatic castration-resistant prostate cancer: effects on cell cycle, cell growth, and tumor development J Natl Cancer Inst 105 2013 1463 1473
135. Z. Wang, L. Wan, J. Zhong, H. Inuzuka, P. Liu, and F.H. Sarkar Cdc20: a potential novel therapeutic target for cancer treatment Curr Pharm Des 19 2013 3210 3214
136. W. Wang, T. Wu, and M.W. Kirschner The master cell cycle regulator APC-Cdc20 regulates ciliary length and disassembly of the primary cilium eLife 3 2014 e03083
137. Y. Wang, and Q. Zhan Cell cycle-dependent expression of centrosomal ninein-like protein in human cells is regulated by the anaphase-promoting complex J Biol Chem 282 2007 17712 17719
138. W. Wei, N.G. Ayad, Y. Wan, G.J. Zhang, M.W. Kirschner, and W.G. Kaelin Jr. Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex Nature 428 2004 194 198
139. C.M. Wiggins, H. Band, and S.J. Cook c-Cbl is not required for ERK1/2-dependent degradation of BimEL Cell Signal 19 2007 2605 2611
140. W.J. Wu, K.S. Hu, D.S. Wang, Z.L. Zeng, D.S. Zhang, and D.L. Chen CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer J Transl Med 11 2013 142
141. S. Yamanaka, N.R. Campbell, F. An, S.C. Kuo, J.J. Potter, and E. Mezey Coordinated effects of microRNA-494 induce G 2/M arrest in human cholangiocarcinoma Cell Cycle 11 2012
142. Y. Yang, A.H. Kim, T. Yamada, B. Wu, P.M. Bilimoria, and Y. Ikeuchi A Cdc20-APC ubiquitin signaling pathway regulates presynaptic differentiation Science 326 2009 575 578
143. M. Yang, B. Li, D.R. Tomchick, M. Machius, J. Rizo, and H. Yu p31comet blocks Mad2 activation through structural mimicry Cell 131 2007 744 755
144. L.P. Yco, G. Mocz, J. Opoku-Ansah, and A.S. Bachmann Withaferin A inhibits STAT3 and induces tumor cell death in neuroblastoma and multiple myeloma Biochem Insights 7 2014 1 13
145. H. Yu Regulation of APC-Cdc20 by the spindle checkpoint Curr Opin Cell Biol 14 2002 706 714
146. H. Yu Cdc20: a WD40 activator for a cell cycle degradation machine Mol Cell 27 2007 3 16
147. B. Yuan, Y. Xu, J.H. Woo, Y. Wang, Y.K. Bae, and D.S. Yoon Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability Clin Cancer Res 12 2006 405 410
148. A. Zaravinos, G.I. Lambrou, I. Boulalas, D. Delakas, and D.A. Spandidos Identification of common differentially expressed genes in urinary bladder cancer PLoS One 6 2011 e18135
149. X. Zeng, and R.W. King An APC/C inhibitor stabilizes cyclin B1 by prematurely terminating ubiquitination Nat Chem Biol 8 2012 383 392
150. X. Zeng, F. Sigoillot, S. Gaur, S. Choi, K.L. Pfaff, and D.C. Oh Pharmacologic inhibition of the anaphase-promoting complex induces a spindle checkpoint-dependent mitotic arrest in the absence of spindle damage Cancer Cell 18 2010 382 395
151. W. Zhang, G.Z. Cheng, J. Gong, U. Hermanto, C.S. Zong, and J. Chan RACK1 and CIS mediate the degradation of BimEL in cancer cells J Biol Chem 283 2008 16416 16426
152. W. Zhang, W. Gong, H. Ai, J. Tang, and C. Shen Gene expression analysis of lung adenocarcinoma and matched adjacent non-tumor lung tissue Tumori 100 2014 338 345
153. J. Zhang, L. Wan, X. Dai, Y. Sun, and W. Wei Functional characterization of anaphase promoting complex/cyclosome (APC/C) E3 ubiquitin ligases in tumorigenesis Biochim Biophys Acta 1845 2014 277 293
154. L. Zhang, B. Yang, K. Zhou, H. Li, D. Li, and H. Gao Potential therapeutic mechanism of genistein in breast cancer involves inhibition of cell cycle regulation Mol Med Rep 11 2015 1820 1826
155. A. Zur, and M. Brandeis Securin degradation is mediated by fzy and fzr, and is required for complete chromatid separation but not for cytokinesis EMBO J 20 2001 792 801